152 related articles for article (PubMed ID: 15716655)
1. Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis.
Parés A; Guañabens N; Rodés J
Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):311-5. PubMed ID: 15716655
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis.
Lakatos LP; Bajnok E; Hegedus D; Tóth T; Lakatos P; Szalay F
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):733-40. PubMed ID: 12169981
[TBL] [Abstract][Full Text] [Related]
3. [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].
Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horváth A; Lakatos P; Szalay F
Orv Hetil; 2004 Feb; 145(7):331-6. PubMed ID: 15049048
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis.
Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horvath A; Lakatos P; Habior A; Szalay F
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):753-9. PubMed ID: 15256976
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis.
Springer JE; Cole DE; Rubin LA; Cauch-Dudek K; Harewood L; Evrovski J; Peltekova VD; Heathcote EJ
Gastroenterology; 2000 Jan; 118(1):145-51. PubMed ID: 10611163
[TBL] [Abstract][Full Text] [Related]
6. Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
Seki A; Ikeda F; Miyatake H; Takaguchi K; Hayashi S; Osawa T; Fujioka SI; Tanaka R; Ando M; Seki H; Iwasaki Y; Yamamoto K; Okada H
J Gastroenterol Hepatol; 2017 Sep; 32(9):1611-1616. PubMed ID: 28114749
[TBL] [Abstract][Full Text] [Related]
7. Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.
Parés A; Guañabens N; Alvarez L; De Osaba MJ; Oriola J; Pons F; Caballería L; Monegal A; Salvador G; Jo J; Peris P; Rivera F; Ballesta AM; Rodés J
Hepatology; 2001 Mar; 33(3):554-60. PubMed ID: 11230734
[TBL] [Abstract][Full Text] [Related]
8. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis.
Guañabens N; Cerdá D; Monegal A; Pons F; Caballería L; Peris P; Parés A
Gastroenterology; 2010 Jun; 138(7):2348-56. PubMed ID: 20178794
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Bone Disease in Primary Biliary Cirrhosis.
Glass LM; Su GL
Gastroenterol Clin North Am; 2016 Jun; 45(2):333-43. PubMed ID: 27261902
[TBL] [Abstract][Full Text] [Related]
10. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
Guañabens N; Parés A; Ros I; Caballería L; Pons F; Vidal S; Monegal A; Peris P; Rodés J
J Hepatol; 2005 Apr; 42(4):573-7. PubMed ID: 15763344
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis and osteoporosis: a case-control study.
Mounach A; Ouzzif Z; Wariaghli G; Achemlal L; Benbaghdadi I; Aouragh A; Bezza A; El Maghraoui A
J Bone Miner Metab; 2008; 26(4):379-84. PubMed ID: 18600405
[TBL] [Abstract][Full Text] [Related]
12. Sodium fluoride prevents bone loss in primary biliary cirrhosis.
Guañabens N; Parés A; del Rio L; Roca M; Gómez R; Muñoz J; Rodés J
J Hepatol; 1992 Jul; 15(3):345-9. PubMed ID: 1447501
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
[TBL] [Abstract][Full Text] [Related]
14. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
15. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
Crippin JS; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797
[TBL] [Abstract][Full Text] [Related]
16. [Bone disease in primary biliary cirrhosis].
Shibata H; Nakao K
Clin Calcium; 2015 Nov; 25(11):1633-8. PubMed ID: 26503867
[TBL] [Abstract][Full Text] [Related]
17. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
[TBL] [Abstract][Full Text] [Related]
18. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
[TBL] [Abstract][Full Text] [Related]
19. Influence of vitamin D receptor gene polymorphism on bone mineral density in primary biliary cirrhosis.
Guardiola J; Xiol X; Nolla JM
Gastroenterology; 2000 Aug; 119(2):599-600. PubMed ID: 10960276
[No Abstract] [Full Text] [Related]
20. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.
Cuthbert JA; Pak CY; Zerwekh JE; Glass KD; Combes B
Hepatology; 1984; 4(1):1-8. PubMed ID: 6693061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
